News
Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Delivering Eye-Popping Gains. Hims & Hers rebounded by 11.76 ...
Gain 2x leveraged exposure to HIMS with HIMZ, ideal for high-risk traders. Read more on how to navigate recent volatility and ...
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
Under the deal, cash-paying patients can access a month’s supply of Wegovy through the Danish drugmaker’s Novocare pharmacy for $299. The one-time price will also be available through Novo’s other ...
Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1. Under the deal, cash-paying patients can access a month's supply ...
PHILADELPHIA − The Eagles selected defensive back Andrew Mukuba with their second-round pick in the NFL Draft on April 25.. Mukuba, taken with the 64th overall pick, the last of the second round ...
Andrew Schneider is the senior reporter for politics and government at Houston Public Media, NPR’s affiliate station in Houston, Texas. In this capacity, he heads the station’s coverage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results